The Pure-Vu EVS System is designed to enhance navigation capabilities in tortuous anatomy. Credit: Motus GI Holdings.

The US Food and Drug Administration (FDA) has granted 510(k) clearance for the commercialisation of Motus GI’s Pure-Vu EVS System.

The new device is designed to enhance navigation capabilities in tortuous anatomy and improve the speed of set-up.

Go deeper with GlobalData

Data Insights

The gold standard of business intelligence.

Find out more

Related Company Profiles

View all

It offers enhanced cleansing capabilities and improved navigation to support expanded clinical utilisation.

During a colonoscopy, the Pure-Vu EVS System helps physicians quickly handle the challenges of a poorly prepared colon.

It is intended to provide significant usability advancements, such as expanded cleansing capacity, on-demand bedside loading, a smaller workstation footprint, and enhanced physician navigation and control.

See Also:

Motus GI CEO Tim Moran said: “The development and innovation we’ve implemented in Pure-Vu EVS is the result of listening to valuable feedback from leading physicians and clinical staff that have utilised our Pure-Vu platform.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

“This FDA clearance of Pure-Vu EVS is expected to allow a greater number of physicians and hospitals to bring this important technology to their patients.

“Additionally, the new EVS oversleeve is able to be loaded on a ‘dirty’ scope in the procedure room, an important new capability that will allow broader utilisation of Pure-Vu to help physicians complete difficult cases and better visualise the colon mucosa.”

The company stated that its Pure-Vu platform fits on standard colonoscopes to enable intraprocedural cleansing of the colon.

It also helps to preserve the established procedural workflow by evacuating debris and irrigating the colon to provide a better examination.

Motus GI plans to commercially launch the Pure-Vu EVS System in the first quarter of the year.